A pilot study of the use of Anafranil in the treatment of phobic disorders is described. Twenty-two patients were included in the investigation, 16 receiving intravenous and oral Anafranil combined and six oral Anafranil alone. After one month, four were free of phobic symptoms and 13 only mildly disabled. At six month follow-up 10 were free of symptoms and seven only mildly disabled.
Get full access to this article
View all access options for this article.
References
1.
MarshallW. K. (1972). Clomipramine intravenous drip. Treatment of obsessional and phobic anxiety states. Nursing Times, 68, 1448–9.
2.
MarshallW. K. (1971). Treatment of obsessional illness and phobic anxiety states with clomipramine. British Journal of Psychiatry, 119, 467–8.
3.
MarksI. M. (1970). The classification of phobic disorders. British Journal of Psychiatry, 116, 377–86.
4.
CollinsG. H. (1973). The use of parenteral and oral chlorimipramine (Anafranil) in the treatment of depressive states. British Journal of Psychiatry, 122, 189–90.
5.
KellyD.GuirguisW.FrommerE.Mitchell-HeggsN.SargantW. (1970). Treatment of phobic states with antidepressants. A retrospective study of 246 patients. British Journal of Psychiatry, 116, 387–98.
